Sildenafil for Oral Suspension is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Sildenafil Citrate.
| Product ID | 69097-903_1baf8602-87b5-46e9-b8c7-bfc88b535f0f |
| NDC | 69097-903 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sildenafil for Oral Suspension |
| Generic Name | Sildenafil Citrate |
| Dosage Form | Powder, For Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-08-18 |
| Marketing Category | ANDA / |
| Application Number | ANDA213041 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | SILDENAFIL CITRATE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-08-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72205-035 | Sildenafil for Oral Suspension | Sildenafil for Oral Suspension |
| 0069-0336 | Revatio | sildenafil citrate |
| 0069-0338 | Revatio | sildenafil citrate |
| 0069-4190 | Revatio | sildenafil citrate |
| 0179-0160 | Sildenafil | sildenafil citrate |
| 27808-163 | Sildenafil | sildenafil citrate |
| 43063-550 | Sildenafil | sildenafil citrate |
| 43353-345 | Sildenafil | sildenafil citrate |
| 50436-0033 | Sildenafil | sildenafil citrate |
| 0904-6671 | SILDENAFIL CITRATE | SILDENAFIL CITRATE |
| 13668-185 | SILDENAFIL CITRATE | SILDENAFIL CITRATE |
| 50090-3905 | SILDENAFIL CITRATE | SILDENAFIL CITRATE |
| 0069-4200 | Viagra | sildenafil citrate |
| 0069-4210 | Viagra | sildenafil citrate |
| 0069-4220 | Viagra | sildenafil citrate |
| 21695-157 | Viagra | sildenafil citrate |
| 21695-158 | Viagra | sildenafil citrate |
| 43063-256 | Viagra | sildenafil citrate |
| 43353-764 | Viagra | sildenafil citrate |
| 50090-0619 | Viagra | sildenafil citrate |